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Abstract
Studies undertaken in recent years have improved our understanding regarding the consequences and
management of febrile urinary tract infections (UTIs), which are amongst the most common serious bacterial
infections in childhood, with renal scarring a frequent outcome.
In the past pyelonephritic scarring of the kidney, often associated with vesico-ureteral reflux (reflux nephropathy)
was considered a frequent cause of chronic renal insufficiency in children. Increasing recognition as a consequence
of improved antenatal ultrasound, that the majority of these children had congenital renal hypo-dysplasia, has
resulted in a number of studies examining treatment strategies and outcomes following UTI.
In recent years there is a developing consensus regarding the need for a less aggressive therapeutic approach with
oral as opposed to intravenous antibiotics, and less invasive investigations, cystourethrography in particular,
following an uncomplicated first febrile UTI. There does remain a concern that with this newer approach we may
be missing a small subgroup of children more prone to develop severe kidney damage as a consequence of
pyelonephritis, and in whom some form of intervention may prove beneficial. These concerns have meant that
development of a universally accepted diagnostic protocol remains elusive.
Febrile urinary tract infections (UTI) have long been
considered amongst the most common serious bacterial
infections in childhood with renal scarring a frequent
outcome [1]. We have recently published a review on
this topic, highlighting developments in our understand-
ing as a consequence of research conducted in this field,
particularly during the past decade [2].
The recognition of an association between UTI, the
presence of vesicoureteral reflux (VUR), and the propen-
sity to develop pyelonephritis with subsequent renal
scarring led to the concept of “reflux nephropathy” [3].
This term implied a causal relationship between VUR,
kidney infection and subsequent major renal damage. As
a consequence aggressive treatment with intravenous
antibiotics, followed by extensive investigation, initially
with urography, later with ultrasound (US) and radionu-
cleotide scintigraphy to detect renal scarring, as well as
voiding cystourethrography (VCUG) to detect and grade
VUR, was strongly encouraged [4]. Furthermore, chil-
dren with VUR were advised to commence long term
antibiotic prophylaxis or undergo surgical correction of
the reflux [5].
More recently, assumptions inherent in the above
approach to UTIs have been questioned. Large regis-
tries, documenting progression to end-stage kidney dis-
ease, failed to show any reduction in the incidence or
frequency as a consequence of aggressive investigation
and management of UTIs [6]. Improved antenatal US
has led to the recognition that congenital abnormalities
of the kidneys and urinary tract (CAKUT), hypo-dyspla-
sia with or without VUR in particular, is more signifi-
cant than acquired pyelonephritic scarring as a causative
factor for chronic renal insufficiency [7].
In recent years, a number of important prospective
clinical trials have improved our understanding, and led
us to critically evaluate previous clinical interventions
and subsequent investigative protocols.
Studies conducted in infants and young children with
uncomplicated febrile UTIs, demonstrated oral antibio-
tics were equally effective as intravenous antibiotics for
the treatment of pyelonephritis [8,9]. There was no sig-
nificant difference in the time to defervescence or rates
of subsequent renal scarring. This allows the potential
for considerable cost savings.
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recurrent UTIs, particularly in the presence of reflux, was
the next to undergo critical appraisal. Four prospective
studies involving 899 children with absent or lesser
grades of VUR demonstrated similar rates of recurrent
UTI in the treatment versus no treatment groups
[10-13], with no significant difference in the incidence of
late scarring in 2 of the studies [10,13]. The first large
scale randomised, placebo controlled trial involving 576
children with absent or any grade of reflux demonstrated
a marginal benefit of antibiotic prophylaxis, however
required 14 patient years of treatment to prevent one
UTI [14]. Recently the Swedish Reflux Study [15]
reported on 203 children aged 1 to 2 years with grade III-
IV dilating VUR, who were randomised to antibiotic pro-
phylaxis, surgical correction or observation. A reduced
rate of recurrent UTI was found in girls in the treatment
groups compared with observation. In addition no scars
occurred in girls on prophylaxis, while those following
surgical intervention or in observation suffered 13 scars.
No treatment benefit was observed in boys.
In these and other prospective studies of febrile UTI
with previously healthy kidneys, around 60% develop pye-
lonephritis, of whom 10-40% will have subsequent scar-
ring [2]. The scarring is usually minor, rarely causing a
reduction in overall kidney function, with the severity
appearing unrelated to the age of the child [16,17].
These and other studies have led to a general consen-
sus regarding the need to temper the investigations fol-
lowing an uncomplicated first febrile UTI. In the past 5
years a range of approaches have been promoted
[18-21]. While no agreement as to an optimal diagnostic
protocol exists, there has be e nas h i f ta w a yf r o mi n v a -
sive procedures and those with a substantial radiation
burden. In particular, the need to detect all but the few
cases of high grade dilating VUR has been questioned,
leading to a marked reduction in the number of VCUGs
performed. Ultrasound remains widely recommended as
a safe non-invasive procedure, however the widespread
use of antenatal US has meant that this modality rarely
detects abnormalities that result in the need for inter-
vention, and appears of limited value following a first
febrile UTI [22,23]. With an increasing focus on the sin-
gle adverse long term outcome of renal scarring, radio-
nucleotide scintigraphy employing technetium
99
dimercaptosuccinic acid (DMSA) scanning has been
recommended by some. The scan is conducted either in
the acute phase following a UTI to confirm pyelonephri-
tis in which case further follow-up and investigation is
advised, the “Top Down” approach [18]; or 6 to 12
months later to confirm the presence of any scarring
that might require ongoing review [23].
There remain a number of significant unresolved
issues.
The development of a universally accepted diagnostic
protocol remains elusive. Such a protocol should detect
the very few children at risk of progressive kidney
damage, who have the propensity to develop the compli-
cations of hypertension, pre-eclampsia and chronic renal
insufficiency; at the same time not subjecting the vast
majority of otherwise healthy children to invasive, costly
and unnecessary interventions.
Many remain concerned that we may be missing a
small subgroup of children more prone to develop
severe kidney damage as a consequence of pyelone-
phritis, and in whom some form of intervention may
prove beneficial. The possibility that various forms of
renal hypo-dysplasia, with and without cystic change,
may predispose to severe scarring as a consequence of
pyelonephritis has not been critically evaluated. The
complex interaction between urinary tract obstruction,
dysfunctional voiding, increased bladder pressure pro-
files and the infection-inflammation process character-
ising pyelonephritis has long been recognised as a
significant issue in progression toward chronic renal
insufficiency, with current intervention strategies often
palliative at most.
Current research is being undertaken to better under-
stand the genetic predisposition and embryologic
mechanisms underlying CAKUT in addition to factors
that might further complicate acquired pyelonephritic
scarring, such as genes involved in inflammation and
fibrosis as well as hypertension [24-27]. Embryologic
studies suggest abnormal laterally displaced ureteral
budding from the bladder wall may predispose to a dys-
plastic refluxing ureter that makes contact with a
reduced amount of mesenchyme forming a smaller
hypo-dysplastic poorly functioning kidney.
Finally future strategies to prevent or ameliorate the
kidney damage caused by pyelonephritis need to be
explored. A recent publication [28] examining steroid
therapy in the acute phase of the infection suggests some
benefit as previously reported in animal models [29].
The “never ending story” of febrile UTIs has received
a lot of attention in recent times, resulting in change
f r o ma na g g r e s s i v et oam o r ec i r c u m s p e c tb u ta l s o
watchful approach to the problem. Physicians should
however remain alert to the possible diagnosis of pyelo-
nephritis in febrile children and treat appropriately.
Where there are atypical features such as lack of
response to appropriate antibiotics, infection with non
E. Coli organisms, or recurrent episodes further evalua-
tion is always warranted.
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